Ottobre 2023

GDMH join forces with Biotechnology Company Ascelia Pharma, which envisions the co-creation and co-development activities on the SPARKLE study held at Fondazione Policlinico Universitario A. Gemelli IRCCS. Ascelia Pharma, a biotech focused on improving the life of people living with rare cancer conditions is conducting the pivotal Phase 3 clinical studySPARKLE with the candidate drug Orviglance, […]

In its quest to empower medical practice with digital medicine solutions, GDMH announces a collaboration with advisory firm EY for the implementation of state-of-the-art blockchain technology in support of its digital platform construction. EY  is a muldisciplinary professional services organization. Its integrated services include Assurance, Advisory, Tax & Law and Strategy & Transactions.